A cascade C-H activation/2-fold annulation of 2-aryloxazolines with pyridotriazoles has been achieved employing Rh-catalysis to afford heteroaryl-tethered oxazoloisoquinolinones. The synergistic annulations, functional group tolerance, and late-stage skeletal editing of the bioactive scaffolds are the salient practical features.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/d4cc06123c | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!